Compare CVS Health Corp (CVS) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.53. The key difference: CVS Health Corp pays a 2.78% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and CVS Health Corp is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| CVS | HYG | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $81.32 |
52-Week Low | $65.51 | $78.72 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
HYG trades at $79.61, up 0.19% on the day, with a bullish technical signal driven by oscillators despite bearish moving averages. Recent dividends include $0.41 paid in June 2026. News highlights bond market volatility amid oil price swings and inflation data anticipation, with HYG noted for its high-yield corporate bond exposure and liquidity as the largest junk bond ETF.
Outlook hinges on interest rate trends and economic stability, offering income through dividends but facing risks from rising yields and credit spreads. Investors should weigh HYG's role in diversified portfolios against potential downside from macroeconomic shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
